-
You must submit the settlement Proof form attached below, in order to participate in this settlement. There is a strict deadline of August 7, 2019 by which all claims must be submitted. The instructions for submitting are included in the Proof and the Notice files attached below for your download. DO NOT SEND THE FORMS TO THE SHAREHOLDERS FOUNDATION, INC.
-
To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Lawsuit Overview
Settlement Overview
You must register to view and download the Settlement Notice and Settlement Proof.
July 22, 2019 - The court granted final approval of the settlement.
March 12, 2019 - The court preliminarily approved the settlement.
February 14, 2019 - A stipulation of settlement was filed by the parties.
March 30, 2018 - A second amended complaint was filed.
March 30, 2018 - The court denied the defendants' motion to dismiss.
April 3, 2017 - A motion to dismiss the amended consolidated complaint was filed.
February 1, 2017 - An amended consolidated complaint was filed.
July 11, 2016 - An investor in shares of Stericycle Inc (NASDAQ: SRCL) filed a lawsuit in the U.S. District Court for the Northern District of Illinois over alleged violations of Federal Securities Laws by Stericycle Inc (NASDAQ: SRCL and SRCLP), its directors, certain of its senior executives, and underwriters of its public securities offering in connection with certain allegedly false and misleading statements made between February 7, 2013 and April 28, 2016.
According to the complaint the plaintiff alleges on behalf of purchasers of Stericycle Inc (NASDAQ: SRCL) common shares between February 7, 2013 and April 28, 2016, that the defendants violated Federal Securities Laws.
More specifically, the plaintiff claims that between February 7, 2013 and April 28, 2016 Stericycle Inc engaged in a systematic scheme whereby it routinely and systematically raised the rates it charged its smaller customers in violation of the contracts it had with those customers and that by doing so, Stericycle Inc artificially inflated its revenues and growth.
The plaintiff claims that the Defendants did not disclose this practice and, as a result, Stericycle Inc routinely misrepresented its performance and earnings. Stericycle Inc reported that its Total Revenue rose from over $1.67 billion in 2011 to over $2.55 billion in 2014 and that its respective Net Income increased from $234.75 million to $326.46 million. Shares of Stericycle Inc (NASDAQ: SRCL) grew from $76.51 per share in late 2011 to as high as $148.25 per share in August 2015.
On September 9, 2015, Stericycle Inc announced the pricing of its public offering of 7,000,000 depositary shares, each of which represents a 1/10th interest in a share of its 5.25% Series A Mandatory Convertible Preferred Stock. The offering price was $100.00 per depositary share.
On October 22, 2015, Stericycle Inc disclosed disappointing growth rates and revenues during the third quarter of 2015 and lowered its guidance going forward.
On April 28, 2016, Stericycle Inc disclosed that its results for the first quarter of 2016 were below its guidance and analysts' expectations, and lowered its 2016 guidance going forward.
Shares of Stericycle Inc declined from $149.48 per share on October 16, 2015 to $91.05 per share on April 29, 2016. ON July 12, 2016, NASDAQ: SRCL shares closed at $105.21 per share.